论文部分内容阅读
我科于1995年1月—1998年1月采用西安杨森公司出品的斯皮仁诺胶囊治疗浅部真菌病患者198例,取得了满意的疗效,现报告如下。 病例选择 临床检查与真菌学检查确诊的门诊和住院病人共198例,其中花斑癣4例,腹癣19例,体癣6例,手癣22例,足癣29例,指甲真菌病56例,趾甲真菌病62例。包括男性106例,女性92例;年龄最小17岁,最大71岁,平均44岁;病程最长35年,最短4周。所有病人在用药前 我科于1995年1月—1998年1月采用西安杨森公司出品的斯皮仁诺胶囊治疗浅部真菌病患者198例,取得了满意的疗效,现报告如下。 病例选择 临床检查与真菌学检查确诊的门诊和住院病人共198例,其中花斑癣4例,腹癣19例,体癣6例,手癣22例,足癣29例,指甲真菌病56例,趾甲真菌病62例。包括男性106例,女性92例;年龄最小17岁,最大71岁,平均44岁;病程最长35年,最短4周。所有病人在用药前体检结果均表明无肝、肾及精神疾患。全部病人在服药前1年内均无门服抗真菌药物史,在治疗期间一律停用所有外用药物。 给药方法 花斑癣,体癣,股癣患者为每日1次,每次200mg,餐后即服,连服1周;手癣,足癣患者为每日2次,每次100mg,连服1周;停药3周为1疗程。指甲真菌病患者用药两个疗程,趾甲真菌病患者用药3个疗程。甲真菌病病人每月随访1次,疗效判定最终时间为末?
Our department in January 1995 - January 1998 by Xi’an Yang Sen company produced Sporanox capsules 198 cases of superficial mycosis patients, and achieved satisfactory results, are as follows. A total of 198 outpatients and inpatients diagnosed by clinical examination and mycological examination were selected. Among them, 4 cases of pityriasis versicolor, 19 cases of psoriasis, 6 cases of body ringworm, 22 cases of hand ringworm, 29 cases of athlete’s foot, 56 cases of nail mycosis , Toenail mycosis in 62 cases. Including 106 males and 92 females; the youngest 17 years old, maximum 71 years old, average 44 years; duration of up to 35 years, the shortest 4 weeks. All patients before treatment in our department in January 1995 - January 1998 by Xi’an Janssen company produced Sporeno capsules in 198 cases of superficial mycosis patients, and achieved satisfactory results, are as follows. A total of 198 outpatients and inpatients diagnosed by clinical examination and mycological examination were selected. Among them, 4 cases of pityriasis versicolor, 19 cases of psoriasis, 6 cases of body ringworm, 22 cases of hand ringworm, 29 cases of athlete’s foot, 56 cases of nail mycosis , Toenail mycosis in 62 cases. Including 106 males and 92 females; the youngest 17 years old, maximum 71 years old, average 44 years; duration of up to 35 years, the shortest 4 weeks. All patients before the drug test results show that no liver, kidney and mental illness. All patients were unpremediated with antifungal medication within 1 year prior to medication and all topical medications were discontinued during treatment. Tinea versicolor, tinea corporis, tinea cruris patients once daily, each 200mg, meal service, even for 1 week; hand ringworm, tinea pedis patients twice daily, each 100mg, with 1 week service; withdrawal 3 weeks for a course of treatment. Nail mycosis patients medication two courses, nail fungal patients medication 3 courses. Onychomycosis patients were followed up once a month, the final determination of efficacy for the end?